| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. (MIRM) has 13 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. MIRM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 194.3K | $20.87M | - | |
| Dir | 181.2K | $19.46M | - | |
| CFO | 49.8K | $5.35M | - | |
| COO | 40.3K | $4.33M | - | |
| Other | 18.9K | $2.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2025 | Howe Jolanda | SVP, Global Controller | Sale+OE | 902 | $47.92 | $43,227.81 | -20.4% | -14.9% | +98.4% | |
| Jan 24, 2025 | Peetz Christopher45 | Chief Executive Officer | Sale+OE | 6,837 | $47.92 | $327,658.44 | -5.2% | -14.9% | +98.4% | |
| Jan 17, 2025 | Quan Joanne | Chief Medical Officer | Sale+OE | 6,969 | $45.86 | $319,598.34 | -55.2% | -16.7% | +93.9% | |
| Jan 7, 2025 | Radovich Peter | President And COO | Sell | 1,998 | $42.82 | $85,544.97 | -6.9% | -2.5% | +94.9% | |
| Jan 7, 2025 | Peetz Christopher45 | Chief Executive Officer | Sell | 7,489 | $42.82 | $320,643.78 | -5.9% | -2.5% | +94.9% | |
| Jan 7, 2025 | Howe Jolanda | SVP, Global Controller | Sale+OE | 750 | $42.82 | $32,111.48 | -20.4% | -2.5% | +94.9% | |
| Nov 14, 2024 | Howe Jolanda | SVP, Global Controller | Sale+OE | 2,500 | $47.10 | $117,752.00 | -50.8% | +9.6% | +54.4% | |
| Sep 18, 2024 | Heron Patrick J86 | Director | Buy | 115 | $37.40 | $4,301.00 | - | +12.5% | +98.7% | |
| Sep 6, 2024 | Heron Patrick J86 | - | Buy | 230 | $41.58 | $9,563.01 | +0.1% | +8.0% | +85.0% | |
| Jul 2, 2024 | Howe Jolanda | SVP, Global Controller | Sale+OE | 375 | $34.00 | $12,750.00 | -13.4% | +15.8% | +45.8% |